Literature DB >> 20694964

SSRI treatment during pregnancy: are we asking the right questions?

Katherine L Wisner1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20694964      PMCID: PMC7054890          DOI: 10.1002/da.20729

Source DB:  PubMed          Journal:  Depress Anxiety        ISSN: 1091-4269            Impact factor:   6.505


× No keyword cloud information.
  18 in total

1.  Fetal exposure to antidepressants and normal milestone development at 6 and 19 months of age.

Authors:  Lars Henning Pedersen; Tine Brink Henriksen; Jørn Olsen
Journal:  Pediatrics       Date:  2010-02-22       Impact factor: 7.124

2.  Teratogenicity of SSRIs--serious concern or much ado about little?

Authors:  Michael F Greene
Journal:  N Engl J Med       Date:  2007-06-28       Impact factor: 91.245

Review 3.  Antidepressant use in pregnancy: new concerns, old dilemmas.

Authors:  Christina Chambers; Eydie Moses-Kolko; Katherine L Wisner
Journal:  Expert Rev Neurother       Date:  2007-07       Impact factor: 4.618

4.  Relapse of major depression during pregnancy in women who maintain or discontinue antidepressant treatment.

Authors:  Lee S Cohen; Lori L Altshuler; Bernard L Harlow; Ruta Nonacs; D Jeffrey Newport; Adele C Viguera; Rita Suri; Vivien K Burt; Victoria Hendrick; Alison M Reminick; Ada Loughead; Allison F Vitonis; Zachary N Stowe
Journal:  JAMA       Date:  2006-02-01       Impact factor: 56.272

5.  Major depression and antidepressant treatment: impact on pregnancy and neonatal outcomes.

Authors:  Katherine L Wisner; Dorothy K Y Sit; Barbara H Hanusa; Eydie L Moses-Kolko; Debra L Bogen; Diane F Hunker; James M Perel; Sonya Jones-Ivy; Lisa M Bodnar; Lynn T Singer
Journal:  Am J Psychiatry       Date:  2009-03-16       Impact factor: 18.112

Review 6.  The management of depression during pregnancy: a report from the American Psychiatric Association and the American College of Obstetricians and Gynecologists.

Authors:  Kimberly A Yonkers; Katherine L Wisner; Donna E Stewart; Tim F Oberlander; Diana L Dell; Nada Stotland; Susan Ramin; Linda Chaudron; Charles Lockwood
Journal:  Gen Hosp Psychiatry       Date:  2009 Sep-Oct       Impact factor: 3.238

7.  Use of selective serotonin-reuptake inhibitors in pregnancy and the risk of birth defects.

Authors:  Sura Alwan; Jennita Reefhuis; Sonja A Rasmussen; Richard S Olney; Jan M Friedman
Journal:  N Engl J Med       Date:  2007-06-28       Impact factor: 91.245

Review 8.  Maternal overweight and obesity and the risk of congenital anomalies: a systematic review and meta-analysis.

Authors:  Katherine J Stothard; Peter W G Tennant; Ruth Bell; Judith Rankin
Journal:  JAMA       Date:  2009-02-11       Impact factor: 56.272

9.  Psychiatric disorders in pregnant and postpartum women in the United States.

Authors:  Oriana Vesga-López; Carlos Blanco; Katherine Keyes; Mark Olfson; Bridget F Grant; Deborah S Hasin
Journal:  Arch Gen Psychiatry       Date:  2008-07

10.  The impact of maternal depression in pregnancy on early child development.

Authors:  T Deave; J Heron; J Evans; A Emond
Journal:  BJOG       Date:  2008-07       Impact factor: 6.531

View more
  3 in total

1.  What happens to mental health treatment during pregnancy? Women's experience with prescribing providers.

Authors:  Linda Weinreb; Nancy Byatt; Tiffany A Moore Simas; Karen Tenner; Judith A Savageau
Journal:  Psychiatr Q       Date:  2014-09

2.  Decision making for depression treatment during pregnancy and the postpartum period.

Authors:  Sapana R Patel; Katherine L Wisner
Journal:  Depress Anxiety       Date:  2011-06-16       Impact factor: 6.505

3.  A tale of 2s: optimizing maternal-child health in the context of antenatal maternal depression and antidepressant use.

Authors:  Tim F Oberlander; Katherine L Wisner
Journal:  Can J Psychiatry       Date:  2012-09       Impact factor: 4.356

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.